Background: Near infrared spectroscopy (NIRS) is widely used to monitor regional cerebral tissue oxygenation (rScO 2 ). We compared rScO 2 values during cardiac surgery in patients with or without new cerebral ischaemic lesions on diffusion weighted magnetic resonance imaging (DWI). We hypothesised patients with new cerebral lesions would have impaired tissue oxygenation reflected in their rScO 2 values. Methods: NIRS and DWI data were collected in 152 elective cardiac surgery patients. Absolute rScO 2 values, duration of desaturation below thresholds (baseline, 10%, and 20%), and accumulated cerebral desaturation load were compared between patients with or without new cerebral lesions on DWI. Primary outcome was time below 10% from rScO 2 baseline. Results: The time below 10% from rScO 2 baseline was significantly longer for patients with new cerebral lesions than for patients without [median (inter-quartile range): 11.0 (0.4; 37.5) min vs 1.8 inter-quartile range: (0.05; 20.9) min, P¼0.02]. Furthermore, they had a higher accumulated desaturation load below baseline (P¼0.02) and 10% below baseline (P¼0.02). Finally, their absolute minimum rScO 2 value was significantly lower (P¼0.01). However, the frequency of patients with desaturation below 10% and 20% was comparable between patients with and without new cerebral lesions. Receiveroperating characteristic curve analysis did not identify a clear-cut critical threshold among the investigated rScO 2 variables. Conclusions: Use of NIRS identified significant group differences in rScO 2 values between patients with or without new ischaemic lesions. However, a critical threshold could not be identified because of a high variation in NIRS values across both groups.
In patients undergoing cardiac surgery, postoperative MRI commonly shows small cerebral infarcts. In a prior study, intraoperative NIRS recordings and postoperative MRI were performed. The authors compared intraoperative cerebral oxygen saturation profiles between patients with or without new infarcts. While there were significant differences in intraoperative cerebral oxygenation, there was no clear critical oxygenation threshold associated with new infarcts.
Stroke, cognitive impairment, and other cerebral complications occur frequently after cardiac surgery.
1,2 Diffusion weighted magnetic resonance imaging (DWI) has revealed that new cerebral ischaemic lesions can occur in more than 50% of patients undergoing cardiac surgery with the use of cardiopulmonary bypass (CPB). 3 To identify patients at risk of cerebral complications, near infrared spectroscopy (NIRS) has gained increasing popularity to monitor regional cerebral tissue oxygenation (rScO 2 ) noninvasively, 4 thereby enabling the physician to counteract a potential ominous effect of cerebral desaturation. Despite this logical approach, intervention algorithms to alleviate cerebral desaturation have in previous randomised studies reported conflicting results, not only in the individual studies, but also in recent meta-analyses. 5e7 We aimed to evaluate the association of intraoperative NIRS variables and the development of new cerebral, ischaemic lesions on DWI after adult cardiac surgery. To our knowledge, the present study is the first to do so. In order to provide a better estimate of a relevant threshold for interventions to alleviate cerebral desaturation, we additionally wanted to identify one or more NIRS variables with predictive ability of new cerebral ischaemic lesions after cardiac surgery.
We hypothesised that patients with new cerebral ischaemic lesions have lower absolute rScO 2 values, more pronounced and frequent desaturations, and higher loads of accumulated cerebral desaturation compared with patients without new ischaemic lesions.
Methods

Trial design
This study is a secondary analysis of a prospective randomised trial, the Perfusion Pressure Cerebral Infarct (PPCI) trial. The study protocol and primary outcome result has been published previously. 3, 8 The PPCI trial was a single-centre, parallel group, 1:1 randomised trial investigating the effect of different MAP levels during CPB on cerebral complications after cardiac surgery.
Participants
All inclusion and exclusion criteria have been published previously. 8 In summary, all participants in the PPCI trial were 18 yr of age or older and undergoing elective or subacute coronary artery bypass grafting (CABG), heart valve surgery with the use of CPB, or both. Written informed consent was obtained from all patients included and allowed for all prespecified and future analysis based on the data collected.
Study setting
The PPCI trial was conducted at Rigshospitalet, University of Copenhagen, Denmark. The PPCI trial was approved by the Regional Ethics Committee in the Capital Region of Denmark (H-3-2013-110) and by the Danish Data Protection Agency (J.no: 30-0805 and 30-1434). The PPCI trial is registered at clinicaltrials.gov (NCT02185885) July 7, 2014. Inclusion for the PPCI trial started July 8, 2014 , and finished January 6, 2016, with the last follow-up 3 months later. Detailed protocols for interventions, anaesthesia, and CPB procedures, and the primary outcome from the PPCI trial have been published previously. 3, 8 DWI evaluated lesions and NIRS measurements were both prespecified outcomes in the PPCI trial and the data analysis exploring the association between NIRS readings and DWI measures was specified before initiation of analysis.
Signal acquisition and analysis
Regional cerebral oximetry
Regional cerebral oximetry was obtained with NIRS monitoring performed using self-adhesive sensors (Medtronic/ Covidien INVOS cerebral/somatic oximetry adult sensors, Somanetics Corporation, Troy, MI, USA) placed bilaterally on the patient's forehead during surgery. The sensors were connected to a Covidien/Medtronic INVOS 5100c cerebral/somatic oximeter monitor (Somanetics Corporation). The NIRS monitor was used in a blinded study mode dedicated for this specific purpose and sampling was performed at a frequency of approximately 0.166 Hz. rScO 2 baseline values were obtained while the patient was breathing room air and marked as an event 1 min after placement of the sensors. All variables analysed were mean values of left and right channel.
Diffusion weighted magnetic resonance imaging
All patients underwent cerebral DWI the day before surgery and again once between postoperative Day 3 and Day 6. The full DWI protocol has been published previously. 8 
Outcome
Regional cerebral oximetry
The number of patients and the duration of a decrease in rScO 2 below baseline, or of at least 10% and 20% relative to baseline, was recorded. Cerebral desaturation load (CDL) was defined as the cumulative area under the curve of desaturation (%) below three specific rScO 2 thresholds over time (min). CDLbaseline, CDL10, and CDL20 refer to accumulated desaturation load below baseline, 10% below baseline, and 20% below baseline, respectively.
Mean rScO 2 was calculated for the entire surgical procedure and exclusively the CPB period, defined by the time-point from full blood flow on CPB until CPB had been weaned. Minimum and maximum rScO 2 value was defined as the lowest and highest recorded value, respectively.
The primary outcome in the present study was the duration of a 10% desaturation below baseline, based on a recently published intervention study. 9 
Diffusion weighted magnetic resonance imaging
All DWI scans conducted were evaluated in a blinded manner by a neuro-radiologist measuring volume (mm 3 ) and number of new ischaemic lesions (n). Furthermore, the anatomic location was determined in relation to end-artery supply [anterior cerebral artery (ACA) or other end-artery] and the type of cerebral lesion (watershed/non-watershed), for stratified analysis to be possible.
Stroke
Stroke was defined by a clinical evaluation with neurologic symptoms indicating stroke during a follow-up until 30 days after surgery.
Statistical analysis
Normally distributed data is presented as mean (standard deviation), otherwise as median and inter-quartile range. Collinearity was explored for all rScO 2 variables in relation to the total procedure time, as procedure time was significantly longer in patients with new cerebral lesions. The low number of clinically overt stroke patients excluded the possibility of performing statistical analysis for this specific sample of patients and therefore data are merely presented using summary statistics.
Stratified analysis for the two treatment groups in the PPCI trial was initially conducted parallel to the overall analysis for the complete PPCI trial population. These analyses were identical. In addition, there was no difference in the primary endpoint in the PPCI trial; cerebral infarct volume, between treatment groups, 3 and therefore the present study reports the analysis for the complete PPCI trial population. No sample size calculation was performed because this study was a secondary analysis in a randomised trial. Statistical power is expressed through the reported confidence intervals.
Statistical analyses were performed using SPSS (IBM Corp., released 2013, IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY, USA).
Results
Of 197 patients included in the PPCI trial, 176 had complete NIRS recordings available for analysis. Combined NIRS and DWI data were available in 152 patients.
Baseline patient characteristics, comorbidities, and intraoperative data are presented in Table 1 . Patients with new cerebral DWI lesions had a lower BMI and more frequently had diabetes. Combined procedures (CABG and valve repair/ replacement) were performed more frequently and the procedure duration and cross-clamp time were significantly longer in patients with new lesions.
Diffusion weighted magnetic resonance imaging
Time below 10% relative to rScO 2 baselinedthe primary outcomedwas significantly longer in patients with new lesions (median 10.98 min vs 1.84 min, P¼0.02).
Furthermore, patients with new cerebral lesions spent longer time below the rScO 2 baseline (P¼0.02). CDLbaseline was approximately three times higher (P¼0.02) and CDL10 was eight times higher in patients with new lesions (P¼0.02). Finally, the minimum rScO 2 level was significantly lower (P¼0.01) in patients with new cerebral lesions ( Table 2) . The frequency of patients with desaturation below 10% or 20% relative to rScO 2 baseline did not differ between patients with and without lesions ( Table 3 and Fig. 1) . Interestingly, 25% of the patients with new cerebral lesions had less than 60 s below 10% relative to baseline rScO 2 . In contrast, 29% of the patients without cerebral lesions had a 10% desaturation for more than 10 min. Approximately 40% of the patients both with and without new cerebral lesions had spent more than 10 min below the 10% desaturation level.
Infarct volume (mm 3 ) and number of new lesions on DWI was not significantly different between patients with and without either a 10% or 20% decrease relative to rScO 2 baseline (Table 4) . ROC curve analyses in relation to time below rScO 2 baseline, time below 10% relative to rScO 2 baseline, CDLbaseline, CDL10, and minimum rScO 2 (Fig. 2) showed statistically significant associations with newly developed cerebral lesions, but the area under the curve was <0.62 for each variable, indicating only modest accuracy, and no optimal cut-off level could be determined.
Analysis based on anatomic location and on type of infarct
There was a tendency towards a more prolonged desaturation measured in patients with lesions in the ACA supply region, but no statistically significant difference was observed between lesions inside and outside the ACA region (Supplementary Table S1 ). Watershed infarcts comprised 70% of all the newly detected lesions. Interestingly, the time below 10% relative to rScO 2 baseline and the CDL10 seemed more pronounced in patients with non-watershed lesions, although numbers did not reach statistical significance.
Stroke patients
Seven patients developed stroke. Among these, two patients developed stroke after the DWI was performed. The remaining five had sufficient NIRS recordings and their NIRS data can be seen in Table 5 as summary statistics. Stroke was identified in one patient during a wake-up call in the ICU. The NIRS recordings for this patient can be seen in the online supplementary data ( Supplementary Fig. S1 ). The remaining patients with stroke were identified between Day 1 and Day 30 after operation.
Discussion
We found that the duration of desaturation in rScO 2 below baseline and 10% below baseline was longer, the accumulated desaturation load (CDLbaseline and CDL10) was increased, and the minimum rScO 2 value was lower in patients with new cerebral ischaemic lesions on DWI. Theoretically, a longer procedure time may lead to more episodes with desaturation and accumulated load of desaturation, and therefore we investigated if there was collinearity between procedure time and rScO 2 variables, which was not the case. Despite these significant findings, the ROC analyses did not provide any clear-cut threshold level for the individual rScO 2 variable. Among patients with new cerebral lesions, rScO 2 variables were not significantly different if the infarct was inside or outside the ACA supply area. Neither did rScO 2 values differ between watershed infarcts and non-watershed lesions.
Two relatively small studies 10, 11 in neonates and infants undergoing cardiac surgery have previously investigated the relationship between NIRS values and subsequent findings on magnetic resonance imaging (MRI). Although results cannot be compared head-to-head with the present study because of different study designs and patient populations, prolonged desaturation was seen in patients with positive MRI findings in both studies. 10, 11 In the earliest study in 2006, Dent and colleagues 11 found that prolonged desaturation (>180 min) below an rScO 2 of 45% (on average 15% below baseline) after the operation was associated with new cerebral ischaemic lesions on MRI in neonates undergoing a Norwood procedure. In contrast, Kussman and colleagues 10 were unable to show an association between time below an rScO 2 of 45% (on average 20e25% below baseline) during surgery to any MRI outcome in infants undergoing biventricular repair. In the latter study, MRI was not performed until 1 yr after surgery, which may have influenced the lack of impact from perioperative observations. Within the last two decades, NIRS has been described as a promising tool to monitor regional cerebral oxygen saturation, and observational studies have demonstrated an association with neurological complications, although not consistently. 9,12e17 However, three recent meta-analyses conclude that despite consistent use of feasible intervention protocols 5e7 aimed at mitigating cerebral desaturation, it is questionable if NIRS monitoring is able to improve outcome, in relation to mortality and the prevention of stroke and kidneydor other organd injuries. However, clinical measures for cerebral damage may improve (e.g. postoperative cognitive dysfunction). This lack of significant improvement in patient organ outcome may be because of a low number of events in the included studies 9 or theoretically relate to several shortcomings: (1) technical limitations, (2) inadequate interventions, or (3) overall poor prediction of cerebral injury by NIRS in the individual patient. From a technical point-of-view, NIRS sensors placed bilaterally on the forehead of the patient emit near-infrared light approximately 12e14 mm into the underlying tissue 18, 19 (skin, scalp, bone, membranes, and finally the frontal lobes), which then travels in a U-shape to reach the sensor again. Depending on the absorption in the chromophores of oxygenated and deoxygenated haemoglobin, the value on the monitor represents the regional oxygenation in a 25/75 ratio of the arterial/ venous contribution. In this respect, NIRS displays the regional tissue oxygenation in the frontal lobes and may for this reason not register cerebral hypoxaemia further away from the NIRS sensors. Therefore, we hypothesised that the monitoring capacity might be better if the ischaemic lesion was located in the ACA supply area, but we found no difference in rScO 2 variables compared with patients having lesions outside the ACA supply area. Another hypothesis was that NIRS might be better at tracking a global hypo-perfusion and for this reason we tested if patients with watershed (border-zone) lesions would have lower rScO 2 values and a higher load of desaturation compared with non-watershed infarcts, but this was not the case either. However, one should bear in mind, that, specifically in cardiac surgery, watershed lesions can also be caused by regional hypo-perfusion related to embolisation, 20, 21 and therefore a mere application of the theory that interprets watershed infarcts as resulting from lower cerebral perfusion pressure is not straightforward in this setting. Inadequate interventions to mitigate cerebral desaturation on NIRS might be the reason for the lack of improvement in patient outcome. Many of the published feasibility studies have applied the algorithm by Denault et al. 22 The first intervention in the algorithm is to avoid hypotension, primarily by giving vasoconstrictors. In a randomised clinical trial, 23 19 There are currently a number of studies indicating that the rScO 2 readings are influenced by extracranial contamination. 18, 24 So far, apart from MAP, none of the other interventions in the treatment algorithm to alleviate cerebral desaturation have been evaluated in a randomised set-up and for this reason we cannot reach any conclusion on their effectiveness. Although ROC analysis demonstrated a significant association, the area under the curve was below 0.62 for all variables. The lack of precision is also illustrated by the observations that one-fourth of the patients with new lesions never desaturated 10% below rScO 2 baseline for longer than 60 seconds and more than one-quarter of the patients without new infarcts had a desaturation below 10% for more than 10 min. These results are in line with what is generally presented in the literature, namely that there is a lack of consensus on how to define severe regional cerebral desaturation and that it is difficult to identify an individual cut-off threshold in order to minimise cerebral complications. 25 This is consistent with a recent study that showed that indvidulalised optimasation of NIRS-guided cerebral oxygenation did not improve cognitive function following adult cardiac surgery. 26 Furthermore, the exact time for recording of baseline values (before vs during anaesthesia related preoxygenation) varies between studies, which impairs interstudy comparisons, as most outcome variables are related to deviations from baseline. For instance, in the present study, the frequency of patients with a 10% or 20% decrease in NIRS values from baseline would have increased markedly, if we had applied baseline values representing the NIRS reading during preoxygenation. Consequently, the predictive value of desaturation at these two levels would be significantly impaired. The clinical impact of covert strokes has not been explored in cardiac surgery patients, but in general, the presence of covert strokes has been associated with an increased risk of a subsequent stroke, dementia, and a more rapid cognitive decline, 27, 28 emphasising the importance of avoiding new cerebral infarcts. Study limitations are related to the fact that this study evaluates a secondary outcome from a randomised clinical trial and therefore no sample size calculation was performed. However, we identified significant differences in rScO 2 variables between patients with and without new lesions, and therefore, we do not seem to have substantial lack of power leading to a type 2 error. Carotid stenosis is known to enhance the risk of cerebral damage during cardiac surgery, 29 but unfortunately the carotid arteries are not routinely examined in our institution and ultrasound of carotids was not part of the PPCI trial screening protocol either. Finally, the postoperative DWI was not performed until Days 3e6, therefore, we cannot exclude that some of the cerebral lesions developed after surgery and therefore are not reflected in NIRS values during the procedure. Study strengths are mainly related to the blinding of the NIRS monitor. Therefore, clinicians were not able to intervene during the intraoperative period in response to deviations in rScO 2 . Also, the subgroup analysis of lesion type and anatomic location is a strength that enhances the interpretation of the results in general. The DWI protocol used in the PPCI trial involved a scan conducted the day before surgery and then again on Days 3e6 after operation, to make sure all lesions were new and in relation to the perioperative phase. This study provides the largest patient material with blinded NIRS data and subsequent cerebral DWI with evident cerebral injury, which is strength in itself.
Conclusion
All rScO 2 variables showed either a tendency towards, or significantly, worse values in patients with new DWI cerebral lesions compared with patients without lesions. However, in the individual patient it was not possible to identify any clearcut threshold associated with the development of new lesions. Further studies are needed to confirm these findings and more importantly studies on how interventions to alleviate cerebral desaturations affect patient outcome.
